Developing a universal influenza vaccine to protect against multiple strains of the virus.
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA VACCINE RESEARCH
This study is all about developing new flu vaccines that can give you better and longer-lasting protection against different types of the flu virus, and it involves testing these vaccines in people to see how safe and effective they are.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11301792 on NIH RePORTER |
What this research studies
This research focuses on creating and testing new influenza vaccine candidates that can provide long-lasting and broad protection against various strains of the influenza virus. The approach includes analyzing immune responses to inform vaccine design, conducting laboratory tests to evaluate how well these vaccines work, and performing clinical trials to assess their safety and effectiveness in humans. Patients may be involved in these trials to help determine the best ways to protect against influenza.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who are at high risk for influenza complications, such as the elderly, young children, and those with underlying health conditions.
Not a fit: Patients who are not at risk for influenza or those who have already received a recent flu vaccine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a universal influenza vaccine that significantly reduces the incidence of flu and its complications.
How similar studies have performed: Previous research has shown promise in developing universal vaccines for influenza, but this approach aims to further innovate and refine those efforts.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Krammer, Florian — Icahn School of Medicine at Mount Sinai
- Study coordinator: Krammer, Florian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.